Kloprogge, F;
Mwandumba, HC;
Banda, G;
Kamdolozi, M;
Shani, D;
Corbett, EL;
Kontogianni, N;
... Sloan, DJ; + view all
(2020)
Longitudinal Pharmacokinetic-Pharmacodynamic Biomarkers Correlate With Treatment Outcome in Drug-Sensitive Pulmonary Tuberculosis: A Population Pharmacokinetic-Pharmacodynamic Analysis.
Open Forum Infectious Diseases
, 7
(7)
, Article ofaa218. 10.1093/ofid/ofaa218.
Preview |
Text
ofaa218.pdf - Published Version Download (426kB) | Preview |
Abstract
BACKGROUND: This study aims to explore relationships between baseline demographic covariates, plasma antibiotic exposure, sputum bacillary load, and clinical outcome data to help improve future tuberculosis (TB) treatment response predictions. METHODS: Data were available from a longitudinal cohort study in Malawian drug-sensitive TB patients on standard therapy, including steady-state plasma antibiotic exposure (154 patients), sputum bacillary load (102 patients), final outcome (95 patients), and clinical details. Population pharmacokinetic and pharmacokinetic-pharmacodynamic models were developed in the software package NONMEM. Outcome data were analyzed using univariate logistic regression and Cox proportional hazard models in R, a free software for statistical computing. RESULTS: Higher isoniazid exposure correlated with increased bacillary killing in sputum (P < .01). Bacillary killing in sputum remained fast, with later progression to biphasic decline, in patients with higher rifampicin area under the curve (AUC)_{0-24} (P < .01). Serial sputum colony counting negativity at month 2 (P < .05), isoniazid C_{MAX} (P < .05), isoniazid C_{MAX}/minimum inhibitory concentration ([MIC] P < .01), and isoniazid AUC_{0-24}/MIC (P < .01) correlated with treatment success but not with remaining free of TB. Slower bacillary killing (P < .05) and earlier progression to biphasic bacillary decline (P < .01) both correlate with treatment failure. Posttreatment recurrence only correlated with slower bacillary killing (P < .05). CONCLUSIONS: Patterns of early bacillary clearance matter. Static measurements such as month 2 sputum conversion and pharmacokinetic parameters such as C_{MAX}/MIC and AUC_{0-24}/MIC were predictive of treatment failure, but modeling of quantitative longitudinal data was required to assess the risk of recurrence. Pooled individual patient data analyses from larger datasets are needed to confirm these findings.
| Type: | Article |
|---|---|
| Title: | Longitudinal Pharmacokinetic-Pharmacodynamic Biomarkers Correlate With Treatment Outcome in Drug-Sensitive Pulmonary Tuberculosis: A Population Pharmacokinetic-Pharmacodynamic Analysis |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1093/ofid/ofaa218 |
| Publisher version: | https://doi.org/10.1093/ofid/ofaa218 |
| Language: | English |
| Additional information: | © The Author(s) 2020. Published by Oxford University Press on behalf of Infectious Diseases Society of America. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/). |
| Keywords: | outcome, pharmacokinetics, pharmacodynamics, standard treatment, tuberculosis |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute for Global Health |
| URI: | https://discovery.ucl.ac.uk/id/eprint/10106745 |
Archive Staff Only
 |
View Item |
